Man, 62, sees killer brain tumour shrink by half within weeks - but HOW did it happen? By Daily Mail Reporter Published: 01:09 GMT, 29 October 2024 | Updated: 01:17 GMT, 29 October 2024 e-mail View comments A man has seen his deadly brain tumour shrink by half thanks to a new radioactive therapy, which experts hope will eradicate the disease. Doctors at University College London Hospitals NHS Foundation Trust (UCLH) are running a clinical trial to treat glioblastoma. Around 3,200 people are diagnosed every year with the disease, which is the most common type of brain tumour in adults.
It kills most patients within 18 months and only 5 per cent live for five years. The researchers’ aim is to cure the disease through injecting low levels of radioactivity directly into the tumour to kill off cancer cells. Paul Read has seen his deadly brain tumour shrink by half thanks to a new radioactive therapy, which experts hope will eradicate the disease.
Here Mr Read is pictured with his wife Pauline The 62-year-old engineer from Luton, is the first patient to take part in the trial and has seen his tumour shrink by half in a matter of weeks. For the procedure, surgeons removed as much tumour as possible before implanting a small medical device called an Ommaya reservoir under the scalp, which connects to the tumour via a small tube Paul Read, a 62-year-old engineer from Luton, is the first patient to take part in the trial and has seen his tumour shrink by half in a matter of weeks. A .